Reference of 261767-10-6, Research speed reading in 2021. The prevalence of solvent effects has motivated developing quantitative kinetic, and theoretical assessments of solvent structures and their interactions with reaction intermediates. In a document type is Patent, and a compound is mentioned, 261767-10-6, Name is Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate, introducing its new discovery.
This invention relates to certain 5-HT 4 receptor modulators, particularly 5-HT 4 receptor antagonists, represented by Formula I: wherein Z is formula (A) or (B): wherein R 1, R 2, R 3, R 4, and R 5 and the other substituents are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds and methods for their use as therapeutic agents.
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Reference of 261767-10-6. In my other articles, you can also check out more blogs about 261767-10-6